Your browser doesn't support javascript.
loading
Outcomes of TP53-mutated AML with evolving frontline therapies: Impact of allogeneic stem cell transplantation on survival.
Badar, Talha; Atallah, Ehab; Shallis, Rory M; Goldberg, Aaron D; Patel, Anand; Abaza, Yasmin; Bewersdorf, Jan P; Saliba, Antoine N; Correia, Guilherme Sacchi De Camargo; Murthy, Guru; Duvall, Adam; Burkart, Madelyn; Stahl, Maximilian; Liu, Yuanhang; Dinner, Shira; Palmisiano, Neil; Litzow, Mark R; Foran, James M.
Afiliação
  • Badar T; Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, Florida, USA.
  • Atallah E; Division of Hematology and Medical Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
  • Shallis RM; Section of Hematology, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Goldberg AD; Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Patel A; Section of Hematology and Oncology, Department of Medicine, University of Chicago, Chicago, Illinois, USA.
  • Abaza Y; Robert H. Lurie Comprehensive Cancer Center, Northwestern Hospital, Chicago, Illinois, USA.
  • Bewersdorf JP; Section of Hematology, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Saliba AN; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Correia GSC; Department of Internal Medicine, Mount Sinai Health System, New York, USA.
  • Murthy G; Division of Hematology and Medical Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
  • Duvall A; Section of Hematology and Oncology, Department of Medicine, University of Chicago, Chicago, Illinois, USA.
  • Burkart M; Robert H. Lurie Comprehensive Cancer Center, Northwestern Hospital, Chicago, Illinois, USA.
  • Stahl M; Department of Hematology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Liu Y; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA.
  • Dinner S; Robert H. Lurie Comprehensive Cancer Center, Northwestern Hospital, Chicago, Illinois, USA.
  • Palmisiano N; Division of Hematology and Oncology, Jefferson University Hospital, Philadelphia, Pennsylvania, USA.
  • Litzow MR; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Foran JM; Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, Florida, USA.
Am J Hematol ; 97(7): E232-E235, 2022 07.
Article em En | MEDLINE | ID: mdl-35338673
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Transplante de Células-Tronco Hematopoéticas Limite: Humans Idioma: En Revista: Am J Hematol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Transplante de Células-Tronco Hematopoéticas Limite: Humans Idioma: En Revista: Am J Hematol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos